Cargando…

Erratum: Achilles' heel of triple negative cancer

Detalles Bibliográficos
Autores principales:	Ocaña, Alberto, Montero, Juan C., Pandiella, Atanasio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549363/ https://www.ncbi.nlm.nih.gov/pubmed/26328268

Ejemplares similares

Achilles' heel of triple negative cancer
por: Ocaña, Alberto, et al.
Publicado: (2014)

Achilles' heel of triple negative cancer
por: Ocaña, Alberto, et al.
Publicado: (2014)

Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies
por: Ocana, Alberto, et al.
Publicado: (2017)

Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2
por: Pandiella, Atanasio, et al.
Publicado: (2015)

Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
por: Cuenca-López, María D, et al.
Publicado: (2014)

Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer
por: Montero, Juan Carlos, et al.
Publicado: (2022)

Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer
por: Noblejas-López, María del Mar, et al.
Publicado: (2019)

Commentary: Achilles' heel
por: Cook, Chris C., et al.
Publicado: (2020)

Cancer's new Achilles' heel?
por: Owen, Gareth I.
Publicado: (2017)

Therapeutic potential of ERK5 targeting in triple negative breast cancer
por: Ortiz-Ruiz, María Jesús, et al.
Publicado: (2014)

Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling
por: Montero, Juan Carlos, et al.
Publicado: (2015)

Personalized therapies in the cancer "omics" era
por: Ocaña, Alberto, et al.
Publicado: (2010)

Erratum to epigenetic hypomethylation and upregulation of GD3s in triple negative breast cancer
Publicado: (2022)

Proteolysis targeting chimeras (PROTACs) in cancer therapy
por: Ocaña, Alberto, et al.
Publicado: (2020)

Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer
por: Corrales‐Sánchez, Verónica, et al.
Publicado: (2020)

Ribosome biogenesis: Achilles heel of cancer?
por: van Sluis, Marjolein, et al.
Publicado: (2014)

Hedgehog Signaling: An Achilles’ Heel in Cancer
por: Niyaz, Madiha, et al.
Publicado: (2019)

Searching for the Achilles Heel of FOXP3
por: Lozano, Teresa, et al.
Publicado: (2013)

The Heel of Achilles in Hospital Diet
Publicado: (1913)

SARS' Achilles' heel revealed
por: Clarke, Tom
Publicado: (2003)

Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets: Erratum
Publicado: (2016)

Erratum to: Channel-assisted minimally invasive repair of acute Achilles tendon rupture
por: Chen, Hua, et al.
Publicado: (2016)

DNA replication stress as an Achilles' heel of cancer
por: Da-Rè, Caterina, et al.
Publicado: (2014)

A new Achilles Heel in breast cancer?
por: Sflomos, George, et al.
Publicado: (2013)

Cancer’s Achilles’ Heel: Apoptosis and Necroptosis to the Rescue
por: Dasgupta, Atreyi, et al.
Publicado: (2016)

Targeting centrosome amplification, an Achilles' heel of cancer
por: Sabat-Pośpiech, Dorota, et al.
Publicado: (2019)

Dual targeting of HER2-positive breast cancer with trastuzumab emtansine and pertuzumab: understanding clinical trial results
por: Ocaña, Alberto, et al.
Publicado: (2018)

Erratum to: Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients
por: Ring, Brian Z., et al.
Publicado: (2016)

Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer
por: Cuenca-López, María Dolores, et al.
Publicado: (2015)

Breast Cancer Heterogeneity and Response to Novel Therapeutics
por: Baliu-Piqué, Mariona, et al.
Publicado: (2020)

HER3 in cancer: from the bench to the bedside
por: Gandullo-Sánchez, Lucía, et al.
Publicado: (2022)

BET inhibitors as novel therapeutic agents in breast cancer
por: Ocaña, Alberto, et al.
Publicado: (2017)

Regulation of the prometastatic neuregulin–MMP13 axis by SRC family kinases: therapeutic implications
por: Orive‐Ramos, Ana, et al.
Publicado: (2017)

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum
por: Zhao, Zitong, et al.
Publicado: (2023)

Barriers of the Human Organism and Their Achilles’ Heels
por: Berencsi, György, et al.
Publicado: (2012)

Calibration: the Achilles heel of predictive analytics
por: Van Calster, Ben, et al.
Publicado: (2019)

Calcineurin: The Achilles’ heel of fungal pathogens
por: Yadav, Vikas, et al.
Publicado: (2023)

Enhanced Antitumoral Activity of Encapsulated BET Inhibitors When Combined with PARP Inhibitors for the Treatment of Triple-Negative Breast and Ovarian Cancers
por: Juan, Alberto, et al.
Publicado: (2022)

COX-2 in cancer: Gordian knot or Achilles heel?
por: Stasinopoulos, Ioannis, et al.
Publicado: (2013)

Cholesterol pathway the Achilles heel in prostate cancer metastasis
por: Heidegger, Isabel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oq9m5rr2vghj853kpsb96q1guu